Research

Research that must survive its own assumptions first.

Caretrap | Stichting Zorgfuik does not turn recurring signals into conclusions by default. We first organise what is publicly visible, formulate testable questions and state clearly what is known, and what is not.

Research agenda

From signal to publication, without skipping steps.

A public dossier helps people recognise a problem. Foundation research tests whether there is a recurring pattern, how it can be measured responsibly and which change can actually be defended.

SignalPublic dossierResearch proposalData collectionPublication in developmentPublishedPilot

Explore all research themes

01Process coordination & process gaps 02Medication, dependence & tapering 03Diagnostic delay 04Health data & data coordination 05Human dignity & system logic

Current research lines

Three trajectories, each at a different stage.

A status is not decoration. It tells visitors what they may reasonably expect from the material.

DUTCH WORKING PAPER 0.2

ACNES in the Netherlands

A recognised diagnosis. Insufficiently measured harm.

21 pages · 16 July 2026

Dutch working paper 0.2Open for review

ACNES in the Netherlands

An English overview of the Dutch evidence audit of incidence estimates, diagnostic delay, costs, treatment outcomes and possible downstream harm.

Core finding: the Netherlands can recognise and treat ACNES, but does not adequately measure how many people are affected or what happens during the pathway.

Language: the explanatory page is in English. The single maintained source PDF is currently available in Dutch only.

Evidence auditExplicit evidence limitsIndependent review needed

Read the English overview Open Dutch PDF

RESEARCH LINE · PART 1

The process gap

Measuring where cross-organisational pathways stall

Review version 0.98 · July 2026

Research proposalReview version 0.98

The process gap

A method-development and feasibility proposal for reconstructing stalled care and support pathways across organisational boundaries.

First question: can the course of one pathway be measured safely, transparently and reproducibly?

This is a research proposal, not a research result. No real cases have yet been measured using the method.

0 measured casesMethodological review neededPart 1 research line

View the method proposal Plain-language explanation

MEDICATION & PATHWAY ANALYSIS

From prescription to black market

Who safeguards the way back?

Research line in development · 2026

Research line in developmentNo publication yet

From prescription to black market: who safeguards the way back from oxycodone?

A planned analysis of prescribing, long-term use, tapering, commercial routes and the connection with illicit availability.

Central question: who remains responsible when a legitimate prescription turns into dependence, stagnation or illicit purchasing?

The research question and evidence base are still being refined. There is no completed publication or PDF yet.

PrescribingTaperingBlack market

View the research outline Explore the theme

Publication standard

Transparent, bounded and useful.

Every publication must state what was investigated, which sources were used, where uncertainty remains and what further research is still required.

Question and method

The research question, selection and method are described in a way others can scrutinise.

Sources and limits

Facts, signals, interpretations and missing data remain clearly separated.

Application

A proposal also names risks, conditions and what must first be tested in practice.